Laboratory of Investigative Dermatology, The Rockefeller University, New York, NY; Weill Cornell/Rockefeller/Sloan Kettering Tri-Institutional MD-PhD Program, New York, NY.
Laboratory of Investigative Dermatology, The Rockefeller University, New York, NY.
J Allergy Clin Immunol. 2021 Jun;147(6):2213-2224. doi: 10.1016/j.jaci.2020.12.651. Epub 2021 Feb 3.
Hidradenitis suppurativa (HS), also known as acne inversa, is a chronic, painful, and burdensome inflammatory disease manifesting in nodules and abscesses, with progression to chronically draining tunnels in later-stage disease.
We sought to determine whether HS tunnels are immunologically active participants in disease activity.
Skin biopsy specimens were obtained by using ultrasound guidance in untreated patients with HS and those enrolled in an open-label study of brodalumab (ClinicalTrials.gov identifier NCT03960268) for patients with moderate-to-severe HS.
Immunohistochemistry of HS biopsy specimens demonstrated that the epithelialized HS tunnels recapitulate the psoriasiform epidermal hyperplasia morphology of the overlying epidermis, displaying molecular inflammation, including S100A7 (psoriasin) positivity, as well as features of epidermal skin, including loricrin, filaggrin, lipocalin-2, and Melan-A positive cells. Tunnels were associated with increased infiltration of T cells, dendritic cells, and neutrophils; formation of neutrophil extracellular traps, and increased expression of psoriasiform proinflammatory cytokines. Unsupervised hierarchical clustering demonstrated a separation of HS samples based on the presence or absence of tunnels. Tunnels isolated by microdissection had higher levels of epithelium-derived inflammatory cytokines compared with the overlying epidermis and healthy controls. Clinically, the size and draining of the tunnels were decreased with treatment with the IL-17RA antagonist brodalumab.
These data suggest that tunnels are a source of inflammation in HS.
化脓性汗腺炎(HS),也称为反向痤疮,是一种慢性、疼痛且负担沉重的炎症性疾病,表现为结节和脓肿,并在疾病后期进展为慢性引流性瘘管。
我们旨在确定 HS 瘘管是否是疾病活动的免疫活性参与者。
使用超声引导在未接受治疗的 HS 患者和接受 Brodalumab(ClinicalTrials.gov 标识符 NCT03960268)治疗的中重度 HS 患者的开放标签研究中获得皮肤活检标本。
HS 活检标本的免疫组织化学显示,复层化的 HS 瘘管再现了上方表皮的银屑病样表皮过度增生形态,表现出包括 S100A7(银屑病素)阳性在内的分子炎症,以及表皮皮肤的特征,包括角蛋白、丝聚合蛋白、脂钙蛋白-2 和 Melan-A 阳性细胞。瘘管与 T 细胞、树突状细胞和中性粒细胞的浸润增加、中性粒细胞细胞外陷阱的形成以及银屑病样促炎细胞因子的表达增加有关。无监督层次聚类显示 HS 样本根据是否存在瘘管而分离。与上方表皮和健康对照组相比,通过显微切割分离的瘘管具有更高水平的上皮源性炎症细胞因子。临床上,IL-17RA 拮抗剂 Brodalumab 的治疗可使瘘管的大小和引流减少。
这些数据表明,瘘管是 HS 炎症的来源。